Drug Profile
Goxalaplatib
Alternative Names: 677116; GSK 677116Latest Information Update: 10 Jul 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline; Human Genome Sciences
- Developer GSK
- Class Cardiovascular therapies
- Mechanism of Action Phospholipase A2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Atherosclerosis
Most Recent Events
- 31 Dec 2005 This compound is still in active development
- 07 Apr 2004 Phase-I clinical trials in Atherosclerosis in USA (unspecified route)